AAM
Azzad Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,607
| Closed | -$1.22M | – | 321 |
|
|
2022
Q4 | $1.22M | Sell |
5,607
-5,263
| -48% | -$1.15M | 0.19% | 186 |
|
|
2022
Q3 | $2.02M | Hold |
10,870
| – | – | 0.2% | 165 |
|
|
2022
Q2 | $2.12M | Buy |
10,870
+5,583
| +106% | +$1.09M | 0.21% | 162 |
|
|
2022
Q1 | $1.5M | Buy |
5,287
+1
| +0% | +$284 | 0.22% | 181 |
|
|
2021
Q4 | $1.99M | Sell |
5,286
-27
| -0.5% | -$10.2K | 0.27% | 148 |
|
|
2021
Q3 | $2.19M | Hold |
5,313
| – | – | 0.32% | 114 |
|
|
2021
Q2 | $1.97M | Sell |
5,313
-1
| -0% | -$370 | 0.29% | 146 |
|
|
2021
Q1 | $1.54M | Buy |
5,314
+1
| +0% | +$290 | 0.26% | 161 |
|
|
2020
Q4 | $1.33M | Hold |
5,313
| – | – | 0.24% | 153 |
|
|
2020
Q3 | $1.2M | Hold |
5,313
| – | – | 0.25% | 145 |
|
|
2020
Q2 | $926K | Hold |
5,313
| – | – | 0.22% | 162 |
|
|
2020
Q1 | $671K | Sell |
5,313
-5,286
| -50% | -$667K | 0.2% | 178 |
|
|
2019
Q4 | $1.73M | Hold |
10,599
| – | – | 0.2% | 168 |
|
|
2019
Q3 | $1.63M | Buy |
10,599
+9,096
| +605% | +$1.4M | 0.2% | 172 |
|
|
2019
Q2 | $213K | Buy |
+1,503
| New | +$213K | 0.06% | 287 |
|
|
2019
Q1 | – | Sell |
-6,438
| Closed | -$729K | – | 300 |
|
|
2018
Q4 | $729K | Hold |
6,438
| – | – | 0.25% | 161 |
|
|
2018
Q3 | $866K | Hold |
6,438
| – | – | 0.23% | 167 |
|
|
2018
Q2 | $723K | Hold |
6,438
| – | – | 0.21% | 182 |
|
|
2018
Q1 | $687K | Hold |
6,438
| – | – | 0.21% | 182 |
|
|
2017
Q4 | $705K | Hold |
6,438
| – | – | 0.22% | 163 |
|
|
2017
Q3 | $695K | Hold |
6,438
| – | – | 0.23% | 158 |
|
|
2017
Q2 | $651K | Buy |
+6,438
| New | +$651K | 0.23% | 158 |
|